Name: Apicidin
Price: 202.00 USD

- Overview
  - Please contact us at for specific academic pricing.
    
    Background
    
    Apicidin, a natural fugal metabolite, is a selective inhibitor of HDAC. Histone deacetylases (HDAC) are enzymes that remove acetyl groups from an ε-N-acetyl lysine amino acid on a histone. It has been revealed that histone acetyltransferase and histone deacetylase play important roles to either transcriptionally activate or repress gene expression through the reversible acetylation of lysine residues on a histone.Apicidin has the potent and broad activity against apicomplexan parasites [1]. It has also been shown to have potent anti-angiogenesis activity and decrease HIF-1a levels in both human and mouse cancer cell lines [2].The component has also been used extensively in vivo study to understand the role of HDAC in different physical processes. Apicidin exhibits anti-proliferative activity against different cancer cells lines in mice [3]. In a human colon HCT-116 carcinoma xenograft model, apicidin suppresses the tumor growth [4]. And it also exhibits the antitumor activity in a Ishikawa cell tumor xenograft model [5].
    
    1.Darkin-Rattray SJ, Gurnett AM, Myers RW, Dulski PM, Crumley TM, Allocco JJ, et al. Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase. Proc Natl Acad Sci U S A 1996,93:13143-13147.
    2.Kim SH, Jeong JW, Park JA, Lee JW, Seo JH, Jung BK, et al. Regulation of the HIF-1alpha stability by histone deacetylases. Oncol Rep 2007,17:647-651.
    3.Han JW, Ahn SH, Park SH, Wang SY, Bae GU, Seo DW, et al. Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin. Cancer Res 2000,60:6068-6074.
    4.Jones P, Altamura S, De Francesco R, Paz OG, Kinzel O, Mesiti G, et al. A novel series of potent and selective ketone histone deacetylase inhibitors with antitumor activity in vivo. J Med Chem 2008,51:2350-2353.
    5.Ahn MY, Chung HY, Choi WS, Lee BM, Yoon S, Kim HS. Anti-tumor effect of apicidin on Ishikawa human endometrial cancer cells both in vitro and in vivo by blocking histone deacetylase 3 and 4. Int J Oncol 2010,36:125-131.
- Properties
  - Alternative Name
    
    (3S,6S,9S,12R)-3-[(2S)-butan-2-yl]-6-[(1-methoxyindol-3-yl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone
    
    CAS Number
    
    183506-66-3
    
    Molecular Formula
    
    C34H49N5O6
    
    Molecular Weight
    
    623.78
    
    Appearance
    
    A crystalline solid
    
    Purity
    
    Purity ≥90.00%
    
    Solubility
    
    Limited solubility, soluble in DMSO or ethanol
    
    Storage
    
    Store at -20°C
    
    * For Research Use Only
- Reference
  - 1. Cheung CHY, Hsu CL, et al. "Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy." Cell Death Dis. 2019 Oct 17;10(11):786. PMID:31624245
    2. Ballante F, Reddy DR, et al. "Structural insights of SmKDAC8 inhibitors: Targeting Schistosoma epigenetics through a combined structure-based 3D QSAR, in vitro and synthesis strategy." Bioorg Med Chem. 2017 Apr 1;25(7):2105-2132. PMID:28259528
    3. Bagnall NH, Hines BM, et al. "Insecticidal activities of histone deacetylase inhibitors against a dipteran parasite of sheep, Lucilia cuprina." Int J Parasitol Drugs Drug Resist. 2017 Apr;7(1):51-60. PMID:28110187

We Also Recommend

MG-262

$378

PAC-1

$450

PAC-1

$220

PAC-1

$188

Panobinostat (LBH589)

$196

Apicidin

Apicidin

Background

We Also Recommend

MG-262

PAC-1

PAC-1

PAC-1

Panobinostat (LBH589)